Compound 6b is a thalidomide-derived VHL E3 ligase ligand conjugated to a linker, designed for constructing PROTAC molecules. This synthetic conjugate is utilized in chemical biology and drug discovery research to study targeted protein degradation in both cellular and preclinical models.
